Warwick and Verdel Instruments researchers have shown that two-dimensional mass spectrometry, previously the preserve of scarce, expensive FT-ICR instruments, can now be performed on a common benchtop quadrupole time-of-flight machine, potentially letting ordinary clinical and research laboratories skip chromatography altogether while pulling more information from complex mixtures.
CellCarta, a global contract research organisation (CRO) laboratory serving the biopharmaceutical industry, has announced the formation of a Digital Pathology and AI Consortium intended to support biomarker discovery, patient stratification and companion diagnostic development across multiple disease areas.
Novogene Europe has expanded its single-cell RNA sequencing capability at its Cambridge Omics Centre, extending workflows built around the 10x Genomics Chromium platform to academic, biotech and biopharma researchers across the UK.
BioMed X, an innovation engine for pharmaceutical research and development based in New Haven, Connecticut, has announced a global call for research proposals focused on neural circuit regulation of immune function. The initiative, supported by Biogen, invites researchers worldwide to submit original concepts examining the relationship between the nervous system and the immune system, with […]
Elevara Medicines, a clinical-stage company developing therapies for rheumatoid arthritis (RA) and other chronic inflammatory conditions, has announced the appointment of Mai-Britt Zocca, PhD, as Chief Executive Officer, effective 1 July 2026. Dr Zocca succeeds founder Emma Tinsley, who will remain with the company as a Non-Executive Director on the Board.
ELRIG, the Cambridge-based not-for-profit, volunteer-led organisation serving the global drug discovery community, has appointed Dr Hitesh Sanganee and Dr Marcus Schindler to its Scientific Advisory Board (SAB).
Navigo Proteins has announced the appointment of Dr Florian Settele as Managing Director of Navigo Pure, its wholly owned subsidiary specialising in downstream bioprocessing.
Autolomous and Cellular Origins have announced integration of their respective platforms, bringing automation and digitisation to the cell therapy manufacturing process. The combined approach establishes a connected manufacturing environment intended to give developers greater standardisation, traceability and control across the manufacturing pathway.
Lilac Biosciences Inc., a life sciences company spun out of the Giuliani RNA Center at Brown University, and Soin Neuroscience have announced the publication of a joint clinical review examining how RNA biomarkers might support the assessment and monitoring of neuropathic pain. The article, “New Insight into RNA Biomarkers in Neuropathic Pain: A Clinician and […]
FairJourney Bio (FJBio) has entered a partnership with AbTherx, Inc. to integrate transgenic mouse-based antibody discovery into its existing discovery and engineering workflow. The agreement, announced at the BIO International Convention 2026, gives FJBio access to AbTherx’s Atlas™ Full Human Diversity (FHD) and Common Light Chain (cLC) mouse technologies.